MATW-PROJECT
28.11.2022 12:12:36 CET | Business Wire | Press release
The ‘Muslims Around the World Project’ (MATW-Project), a new-generation non-governmental organization building heritage with global impact, was founded by Ali Banat, who passed away from cancer at a young age. To acknowledge his contribution, TRT World Citizen Awards, an organization that honors people who contribute greatly to society, has granted Ali Banat its Lifetime Achievement Award. Mahmoud Ismail, Ali Banat's friend and the CEO of MATW-Project, received the award at the ceremony in Istanbul on November 25 from TRT World, the international English language broadcaster operated by Turkiye's national broadcaster TRT.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005245/en/
CEO of MATW-Project Mahmoud Ismail and TRT Director General Prof. Zahid Sobacı (Photo: Business Wire)
Ali Banat was an Arab-Australian businessperson who owned a security and electrical company and died in 2018, following a struggle with cancer. Following his cancer diagnosis in October 2015, Ali Banat donated all his wealth to charity and founded MATW-Project.
Mahmoud Ismail expressed his thoughts about the award, saying, "We lost Ali Banat but his legacy lives on in what he did for the world and for charity. His MATW-Project, based in Australia, carries on its business with a strong presence in many countries worldwide, especially in Africa. We would like to thank TRT World for recognizing the contributions of MATW to the world and granting this award to our founder Ali Banat."
This year, the TRT World Citizen Awards held its award ceremonies for the third time. The ceremony was attended by many international people from different parts of society, such as politics, academia, arts, entertainment, humanitarian aid, and business.
This non-profit organization cherishes Ali Banat's legacy and contributes to positive change worldwide. With its 774,000 supporters on social media, the MATW-Project has built more than 950 water wells in Africa to make up for the water shortage, supported more than 1,000 orphan children and touched the lives of more than 3 million people.
The MATW-Project operates on a 100% donation basis, meaning that every donated amount is given to those in need, and provides humanitarian support in countries such as Bangladesh, Pakistan, Palestine, Yemen, Syria, and Afghanistan. It also provides shelter, access to water, education and guidance services in challenging living conditions.
Explaining that they want to maximize the impact of donations through a sustainable model, Ismail concluded his speech: "At the MATW-Project, we strive to build equitable and fair living conditions compatible with human dignity; inspired by our values of reliability, efficiency, sustainability, impact, and belief. I hope that this Lifetime Achievement Award from TRT World to our Founder Ali Banat will help further raise awareness of the MATW-Project's activities by reaching more people around the globe."
Visit us at https://matwproject.org
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005245/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis22.4.2026 07:00:00 CEST | Press release
FDA Fast Track Designation granted to 4P004 for the treatment of knee osteoarthritis, recognizing the disease as a serious condition with significant unmet medical need Designation supports enhanced regulatory interactions and alignment on efficient post-Phase 2a development strategies, including potential accelerated pathways 4Moving Biotech (4MB), a clinical-stage biotechnology company developing next-generation Disease-Modifying Osteoarthritis Drugs (DMOADs), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to 4P004 for the treatment of knee osteoarthritis in patients with synovitis who have not benefited from at least two prior pharmacological therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421591087/en/ 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis This designation highlight
LTM Wins Two Google Cloud Partner of the Year Awards for 202622.4.2026 04:30:00 CEST | Press release
Recognised for its Media & Entertainment Industry Solutions and Infrastructure Modernization at Scale LTM, the Business Creativity partner to the world’s largest enterprises, announced today that it has received two Google Cloud Partner of the Year 2026 Awards. LTM is being recognized for its achievements in the Google Cloud ecosystem, helping joint customers to drive high-impact, scalable cloud transformations. LTM won the Google Cloud Partner of the Year Award in the Media & Entertainment category by modernizing a global media company's complex data estate with BigQuery. The transformation improved speed, lowered costs, and provided a scalable foundation, enabling real-time analytics and AI-ready pipelines. This approach offers a repeatable model for data modernization in Media and Entertainment industry. Additionally, LTM was honoured with another Google Cloud Partner of the Year Award for Infrastructure Modernization in North America and the transformation of the ERP landscape for
Horse Powertrain Reveals Lightweight Hybrid V6 System at Beijing Auto Show 202622.4.2026 01:01:00 CEST | Press release
Horse Powertrain, a global leader in innovative and low-emission powertrain systems, has revealed the HORSE W30 – the company’s first production-ready V6 engine – ahead of the Beijing Auto Show 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421176701/en/ The front view of the HORSE W30 engine. The HORSE W30 marks a first for Horse Powertrain, in transferring its expertise in developing optimized three- and four-cylinder engines into the V6 category. By deploying its expertise in this way, Horse Powertrain has developed the lightest V6 on the market and created a hybrid-first V6 with outstanding fuel economy and efficiency. The HORSE W30 is a 3-liter engine that can be fitted in a transverse or longitudinal configuration, allowing it to be packaged in a wide variety of vehicles. The two rows of cylinders are offset at an angle of 90° to lower the engine’s center of gravity, improving ease of installation and optimizi
Montrose Environmental Group Is Now Onterris21.4.2026 22:05:00 CEST | Press release
Earth Day launch of new, unified brand highlights commitment “For Planet & Progress” Montrose Environmental Group (NYSE: MEG, changing to ONT May 4, 2026) will mark Earth Day by rebranding to Onterris. The new, unified brand reflects a purpose and broader role in tackling complex environmental challenges with scientific rigor, operational quality and precise execution. It also aligns expertise and market awareness to position the Company for its next phase of growth. Founded 14 years ago and operating across the U.S., Canada and Australia, the Company is a leading pure-play environmental solutions provider. While the name is new, the mission remains unchanged: advancing our way of life without compromising the integrity of our environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420842892/en/ At the heart of the new brand is a guiding principle: For Planet & Progress. “Onterris is more than a new name. This brand r
SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock21.4.2026 22:00:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the closing of its previously announced underwritten secondary public offering of 3,100,000 shares of the Company’s common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. The proceeds from the offering to the Selling Stockholder were approximately $10.1 million, before deducting underwriting discounts and commissions. The Company did not sell any shares of its common stock in the offering. The Selling Stockholder received all of the proceeds from the offering. Maxim Group LLC acted as the sole book-running manager and Roth Capital Partners acted as the co-manager for the offering. The offering was made pursuant to the Company’s effective shelf registration statement on Form S-3, including a base prospectus, filed with the U.S. Secur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom